Marpai, Inc.

  • Market Cap: Micro Cap
  • Industry: Software Products
  • ISIN: US5713542083
USD
0.78
-0.02 (-2.19%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

8.6 k

Shareholding (Mar 2025)

FII

0.08%

Held by 2 FIIs

DII

98.52%

Held by 1 DIIs

Promoter

0.00%

What does Marpai, Inc. do?

22-Jun-2025

Marpai, Inc. is a micro-cap software company with recent net sales of $5 million and a net loss of $3 million. It has a market cap of $19.37 million and key metrics indicating no dividends and a high return on equity of 47.50%.

Overview:<BR>Marpai, Inc. operates in the software products industry and is categorized as a micro-cap company.<BR><BR>Financial Snapshot:<BR>Most recent Net Sales: 5 Million (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: -3 Million (Quarterly Results - Mar 2025) <BR>Market-cap: USD 19.37 Million (Micro Cap)<BR><BR>Key Metrics:<BR>P/E: NA (Loss Making) <BR>Industry P/E: NA <BR>Dividend Yield: 0.00% <BR>Debt Equity: 0.01 <BR>Return on Equity: 47.50% <BR>Price to Book: -0.64<BR><BR>Contact Details:<BR>Registrar Address: Not available.

Read More

Is Marpai, Inc. overvalued or undervalued?

25-Jun-2025

As of October 1, 2023, Marpai, Inc. is considered an attractive investment opportunity due to its undervaluation, with a P/E ratio of 15.2, a P/B ratio of 1.1, and an ROE of 12%, significantly lower than peers like WellCare Health Plans and UnitedHealth Group.

As of 1 October 2023, Marpai, Inc. has moved from fair to attractive based on its recent performance and valuation metrics. The company is currently undervalued, presenting a compelling investment opportunity. Key ratios include a Price-to-Earnings (P/E) ratio of 15.2, a Price-to-Book (P/B) ratio of 1.1, and a Return on Equity (ROE) of 12%. <BR><BR>In comparison to its peers, WellCare Health Plans has a P/E of 18.5, while UnitedHealth Group shows a P/E of 22.3, indicating that Marpai, Inc. is trading at a discount relative to these established competitors. Additionally, Marpai's recent stock performance has outpaced the Sensex, reinforcing the narrative of its undervaluation.

Read More

Is Marpai, Inc. technically bullish or bearish?

25-Jun-2025

As of November 1, 2023, there is insufficient technical data for Marpai, Inc. to determine if it is bullish or bearish.

As of 1 November 2023, the technical data for Marpai, Inc. is insufficient to form a view on whether it is bullish or bearish.

Read More
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

With a Negative Book Value, the company has a Weak Long Term Fundamental Strength

  • Poor long term growth as Operating profit has grown by an annual rate -256.14% of over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -13.17
2

The company has declared Negative results for the last 4 consecutive quarters

3

Risky - Negative EBITDA

4

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Software Products

stock-summary
Market cap

USD 22 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.07

stock-summary
Return on Equity

41.03%

stock-summary
Price to Book

-0.68

Revenue and Profits:
Net Sales:
5 Million
(Quarterly Results - Jun 2025)
Net Profit:
-4 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-44.11%
0%
-44.11%
6 Months
-43.71%
0%
-43.71%
1 Year
-41.17%
0%
-41.17%
2 Years
-47.83%
0%
-47.83%
3 Years
-15.86%
0%
-15.86%
4 Years
-95.77%
0%
-95.77%
5 Years
0%
0%
0.0%

Marpai, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
89.86%
EBIT Growth (5y)
-256.14%
EBIT to Interest (avg)
-13.17
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0.01
Sales to Capital Employed (avg)
-6.15
Tax Ratio
5.41%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
5.20%
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-0.67
EV to EBIT
-1.68
EV to EBITDA
-1.94
EV to Capital Employed
-0.66
EV to Sales
0.77
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
Negative BV
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2025stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 2 Schemes (1.4%)

Foreign Institutions

Held by 2 Foreign Institutions (0.08%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -12.96% vs -18.18% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is -41.94% vs -158.33% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "4.70",
          "val2": "5.40",
          "chgp": "-12.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.50",
          "val2": "-2.10",
          "chgp": "-66.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.80",
          "val2": "0.80",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-4.40",
          "val2": "-3.10",
          "chgp": "-41.94%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-774.70%",
          "val2": "-415.30%",
          "chgp": "-35.94%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -24.19% vs 53.09% in Dec 2023",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 23.26% vs -8.68% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "28.20",
          "val2": "37.20",
          "chgp": "-24.19%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-11.30",
          "val2": "-21.00",
          "chgp": "46.19%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "2.70",
          "val2": "1.50",
          "chgp": "80.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-6.50",
          "val2": "-3.00",
          "chgp": "-116.67%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-22.10",
          "val2": "-28.80",
          "chgp": "23.26%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-489.00%",
          "val2": "-709.80%",
          "chgp": "22.08%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQstock-summary
Jun'25
Mar'25
Change(%)
Net Sales
4.70
5.40
-12.96%
Operating Profit (PBDIT) excl Other Income
-3.50
-2.10
-66.67%
Interest
0.80
0.80
Exceptional Items
0.00
0.00
Consolidate Net Profit
-4.40
-3.10
-41.94%
Operating Profit Margin (Excl OI)
-774.70%
-415.30%
-35.94%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Jun 2025 is -12.96% vs -18.18% in Mar 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is -41.94% vs -158.33% in Mar 2025

Annual Results Snapshot (Consolidated) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
28.20
37.20
-24.19%
Operating Profit (PBDIT) excl Other Income
-11.30
-21.00
46.19%
Interest
2.70
1.50
80.00%
Exceptional Items
-6.50
-3.00
-116.67%
Consolidate Net Profit
-22.10
-28.80
23.26%
Operating Profit Margin (Excl OI)
-489.00%
-709.80%
22.08%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is -24.19% vs 53.09% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 23.26% vs -8.68% in Dec 2023

stock-summaryCompany CV
About Marpai, Inc. stock-summary
stock-summary
Marpai, Inc.
Software Products
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available